Locked nucleic acid-modified antisense miR-92a (LNA-miR-92a) ameliorated angiotensin II (Ang II)-induced hypertension in mice, which suggests a therapeutic potential of miR-92a antagonists in ameliorating arterial stiffness. The gene discussed is AGT; the disease is hypertensive disorder.